The DHS Program User Forum
Discussions regarding The DHS Program data and results
Home » Topics » Service Provision Assessment (SPA) » Bangladesh Health Facility Survey 2017 (Availability of Tetanus toxoid vaccine and injectable insulin at health facilities in Bangladesh)
Re: Bangladesh Health Facility Survey 2017 [message #22009 is a reply to message #21988] Tue, 19 January 2021 09:52 Go to previous message
Bridgette-DHS is currently offline  Bridgette-DHS
Messages: 3230
Registered: February 2013
Senior Member

Following is a response from SPA Survey Specialist, Rajendra Dangol:

In 2017 BHFS, the TT vaccine information for maternal services can be found in Q1022 (01) and Q1027 (01) where the TT vaccine usually kept with other vaccines in a common vaccination area.

The specification used for the "Injectable glucose solution" variable is Q903(15)=GLUCOSE INJECTABLE SOLUTION should be matching with the report results. However, you used Q903(18)=INSULIN INJECTIONS [ANTI DIABETIC]. Please use Q903(15) instead of Q903(18).

The Specification used for variable "Injectable insulin" should be Q903 (18) as mentioned earlier; there were different variables (other than Q903 (18)) that were included in the definition of "Injectable insulin" in the report that lead to the difference; we are currently reviewing these variables but you can use only Q903 (18) for this indicator.


 
Read Message
Read Message
Previous Topic: Medicine Availability for routine antenatal care in Bangladesh
Next Topic: Replicating table 6.4 and 6.6 of Bangladesh SPA 2017
Goto Forum:
  


Current Time: Tue Aug 12 09:21:38 Coordinated Universal Time 2025